Otilimab ELISA Kit

Product Specifications

Background

Otilimab is an IgG1 mAb that binds to GM-CSF and hinders its interaction with GM-CSFRα; it was developed by Morphosys AG (MOR-103) and then sublicensed to GSK (GSK3196165) to conduct large-scale clinical trials.

Specifications

Otilimab

Product Name Alternative

MOR-04357, 3196165, GSK3196165, MOR103, CAS: 1638332-55-4

Detection Method

Colorimetric

Assay Type

Quantitative

Sample Type

Plasma, Serum

Detection Range

0.31-5 μg/mL

Recovery

80-120%

Sensitivity

0.156 μg/ml

Shipping Conditions

2-8 °C

Storage Conditions

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.